Shuttle Pharmaceuticals Holdings (SHPH) Common Equity (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Common Equity of $3.3 million for Q1 2026, up 1.86% year-over-year from $3.3 million in Q1 2025, and up 48.43% quarter-over-quarter from $2.3 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Common Equity (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Common Equity history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Common Equity rose 1.86% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 1.86% YoY), while the FY2025 annual figure was $2.3 million, up 217.91% from the prior year.
- Common Equity for Q1 2026 stood at $3.3 million, up from $2.3 million in the prior quarter.
- The five-year high for Common Equity was $8.4 million in Q3 2022, with the low at -$2.3 million in Q2 2022.
- The 5-year median for Common Equity is $3.3 million (2025), against an average of $3.1 million.
- The sharpest annual moves came in 2022 and 2024: Common Equity surged 535.2% in 2022, then slumped 123.45% in 2024.
- Shuttle Pharmaceuticals Holdings' Common Equity stood at $7.7 million in 2022, then plunged by 47.18% to $4.1 million in 2023, then slumped by 82.51% to $709152.0 in 2024, then jumped by 217.91% to $2.3 million in 2025, then soared by 48.43% to $3.3 million in 2026.
- Business Quant data shows SHPH's Common Equity at $3.3 million in Q1 2026, $2.3 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.29 Mn |
| Dec 31, 2024 | 709,152.00 |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | 801,434.00 |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 5.61 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 6.91 Mn |
| Dec 31, 2022 | 7.68 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | -2.31 Mn |
| Mar 31, 2022 | -1.85 Mn |
| Dec 31, 2021 | -1.76 Mn |
| Sep 30, 2021 | -2.09 Mn |